Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia
暂无分享,去创建一个
G. Parker | J. Hanover | R. Cooksey | D. McClain | D. Love | W. A. Lubas | M. Hazel | Mark W. Hazel
[1] R. Considine. Regulation of Leptin Production , 2001, Reviews in Endocrine and Metabolic Disorders.
[2] R. Considine,et al. Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. , 2002, Endocrinology.
[3] S. Dimmeler,et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.
[4] J. Hanover. Glycan‐dependent signaling: O‐linked N‐acetylglucosamine , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] G. Hart,et al. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. , 2001, Biochemistry.
[6] Xiaoyong Yang,et al. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.
[8] Gerald W. Hart,et al. Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc , 2001, Science.
[9] R. T. Hoffman,et al. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. , 2000, Diabetes.
[10] I. G. Fantus,et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] W. Ambrosius,et al. Hexosamines regulate leptin production in human subcutaneous adipocytes. , 2000, The Journal of clinical endocrinology and metabolism.
[12] G. Hart,et al. O-Glycosylation of Nuclear and Cytosolic Proteins , 2000, The Journal of Biological Chemistry.
[13] R. Cooksey,et al. Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. , 2000, Diabetes.
[14] J. Flier,et al. Obesity and insulin resistance. , 2000, The Journal of clinical investigation.
[15] L. Rossetti. Perspective: Hexosamines and nutrient sensing. , 2000, Endocrinology.
[16] R. Cooksey,et al. Hexosamines stimulate leptin production in transgenic mice. , 2000, Endocrinology.
[17] G. Hart,et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] I. G. Fantus,et al. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. , 2000, Diabetes.
[19] J. Hanover,et al. Functional Expression of O-linked GlcNAc Transferase , 2000, The Journal of Biological Chemistry.
[20] S. Mudaliar,et al. Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects1. , 1999, Endocrinology.
[21] R. Coleman,et al. Nutritional regulation of leptin in humans , 1999, Diabetologia.
[22] R. Cooksey,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6- Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Revers , 2022 .
[23] J. Hanover,et al. Elevated O-LinkedN-Acetylglucosamine Metabolism in Pancreatic β-Cells , 1999 .
[24] N. Barzilai,et al. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat , 1998, Nature.
[25] D. McClain,et al. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. , 1998, Metabolism: clinical and experimental.
[26] I. Han,et al. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility , 1997, Molecular and cellular biology.
[27] Wei Chen,et al. Role of the glucosamine pathway in fat-induced insulin resistance. , 1997, The Journal of clinical investigation.
[28] J. Hanover,et al. O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.
[29] G. Hart,et al. Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.
[30] M. Williams,et al. Development of Insulin Resistance in 3T3-L1 Adipocytes* , 1997, The Journal of Biological Chemistry.
[31] N. Barzilai,et al. The Tissue Concentration of UDP-N-acetylglucosamine Modulates the Stimulatory Effect of Insulin on Skeletal Muscle Glucose Uptake* , 1997, The Journal of Biological Chemistry.
[32] J. Olefsky,et al. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[33] D. McClain,et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. , 1996, The Journal of clinical investigation.
[34] D. McClain,et al. Hexosamines and Insulin Resistance , 1996, Diabetes.
[35] R. Henry,et al. Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. , 1996, The Journal of clinical investigation.
[36] A. Baron,et al. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. , 1995, The Journal of clinical investigation.
[37] Wei Chen,et al. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. , 1995, The Journal of clinical investigation.
[38] M. Buse,et al. Pre-Exposure to Glucosamine Induces Insulin Resistance of Glucose Transport and Glycogen Synthesis in Isolated Rat Skeletal Muscles: Study of Mechanisms in Muscle and in Rat-1 Fibroblasts Overexpressing the Human Insulin Receptor , 1993, Diabetes.
[39] S. Seino,et al. Human GLUT4/Muscle-Fat Glucose-Transporter Gene: Characterization and Genetic Variation , 1992, Diabetes.
[40] A. Paterson,et al. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Marshall,et al. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.
[42] R. Tjian,et al. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.
[43] M. Willingham,et al. O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. , 1987, The Journal of biological chemistry.
[44] L. Gerace,et al. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins , 1987, The Journal of cell biology.
[45] G. Hart,et al. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. , 1986, The Journal of biological chemistry.
[46] G. Hart,et al. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.